Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Brain tissue bank for traumatic brain injury patients undergoing contusion removal

Official title: Study of Pathological and Regenerative Molecular and Cellular Processes Triggered After Traumatic Brain Injury: Analysis of Biopsy Specimens

Run by Mario Negri Institute for Pharmacological Research · NCT07683169 · Data updated 2026-11-12

This study collects brain tissue discarded during surgery for contusions in adults with traumatic brain injury to see if molecular changes relate to injury progression and recovery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorMario Negri Institute for Pharmacological Research
Academic / other
Locations2 sites (Bergamo and 1 other locations)
StatusRecruiting
StartedOctober 18, 2024
Main results expectedOctober 2044
Study endsOctober 2044
Registry record updatedJuly 6, 2026
Trial IDNCT07683169 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+ years) with traumatic brain injury undergoing neurosurgical removal of a cerebral contusion and who can provide informed consent.

Probably not a fit

Patients whose tissue does not yield actionable molecular insights or whose condition prevents meaningful correlation with clinical data may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

TRAUMAP is an observational program that uses surgically resected contused brain tissue from adults with TBI. The collected tissue will be analyzed histologically, biochemically, and molecularly to explore pathways involved in inflammation, cell death, degeneration, and repair. Researchers will correlate molecular findings with patient characteristics to improve understanding of TBI biology and identify potential therapeutic targets. No additional procedures are performed beyond standard care, and only tissue that would otherwise be discarded is used.

Why it matters

Potential benefit: If successful, findings could inform future treatments aiming to reduce secondary brain injury and promote repair.

How similar studies have gone: Other brain tissue studies have yielded valuable insights into neuroinflammation and neurodegeneration, supporting the potential usefulness of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged ≥18 years.
* Diagnosis of traumatic brain injury (TBI).
* Admission to the intensive care unit.
* Clinical indication for neurosurgical evacuation of a cerebral contusion.
* Written informed consent to participate to the study.

Exclusion Criteria:

* Coagulation disorders or other contraindications to the planned neurosurgical procedure.

Where it's running

  • Asst Papa Giovanni Xxiii
    Bergamo, Italy
    Recruiting
  • Fondazione IRCCS San Gerardo dei Tintori
    Monza, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.